Regulatory Coordinator - Pediatric Oncology Solid Tumor Program
Job ID: 33721
Location:
450 Brookline Ave, Boston, MA 02215
Category:
Clinical Research
Employment Type:
Full time
Work Location:
Full Remote: Never on Campus
Overview
Located in Boston and the surrounding communities, Dana-Farber Cancer Institute is a leader in life changing breakthroughs in cancer research and patient care. We are united in our mission of conquering cancer, HIV/AIDS and related diseases. We strive to create an inclusive, diverse, and equitable environment where we provide compassionate and comprehensive care to patients of all backgrounds, and design programs to promote public health particularly among high-risk and underserved populations. We conduct groundbreaking research that advances treatment, we educate tomorrow's physician/researchers, and we work with amazing partners, including other Harvard Medical School-affiliated hospitals.
Responsibilities
The Pediatric Solid Tumor Program at Dana-Farber Cancer Institute is seeking to hire a motivated Regulatory Coordinator (RC) to work within the Clinical Translational Research Program (CTIP) on trials specific to the Solid Tumor Clinical Trials portfolio. The pediatric Solid Tumor Program is one of the largest in the world and treats children with a range of solid tumor diagnoses providing novel and cutting edge therapies for these rare diseases.
The Regulatory Coordinator (RC) will work under the direction of the clinical trial Principal Investigator(s), the CTIP Associate Director, and CTIP Clinical Research Manager to complete the regulatory requirements relevant to each clinical research project. The RC coordinates aspects of protocol submissions, prepares and submits regulatory documents, and maintains records on assigned studies to ensure regulatory compliance with DFCI and DF/HCC policies as well as federal regulation and ICH/GCP guidelines. This position will work collaboratively with a variety of personnel at all levels, including faculty and study team members of DF/HCC and external institutions, cooperative groups, clinical trials experts, representatives from the pharmaceutical industry, federal agencies, and other research organizations. RCs will work with the Office for Human Research Studies (OHRS), Office of Data Quality (ODQ) and the Clinical Trials Offices at the various DF/HCC institutions.
RCs have the opportunity to develop a deep understanding of the clinical trial process and the importance of the regulatory role in bringing novel therapies to pediatric oncology patients. It is anticipated that this job opportunity will lead to educational opportunities as well as the prospect for advancement within the division and the Institute.
Regulatory Compliance:
Clinical Trial Management:
Key Stakeholder Interfacing:
Leadership and Professionalism:
Qualifications
Must be able to perform day to day responsibilities duties as described above with regular and ongoing training and supervision. Attains and can demonstrate fundamental knowledge and is somewhat proficient in some or all of the following areas: DFCI, DF/HCC, ICH/GCP, FDA policy / guidance / regulation; an understanding of the IRB submission & approval process; Regulatory Binder maintenance; PI Initiated / Multi-Center Trials; protocol and consent design and development and FDA IND and other regulatory required submissions.
At Dana-Farber Cancer Institute, we work every day to create an innovative, caring, and inclusive environment where every patient, family, and staff member feels they belong. As relentless as we are in our mission to reduce the burden of cancer for all, we are equally committed to diversifying our faculty and staff. Cancer knows no boundaries and when it comes to hiring the most dedicated and diverse professionals, neither do we. If working in this kind of organization inspires you, we encourage you to apply.
Dana-Farber Cancer Institute is an equal opportunity employer and affirms the right of every qualified applicant to receive consideration for employment without regard to race, color, religion, sex, gender identity or expression, national origin, sexual orientation, genetic information, disability, age, ancestry, military service, protected veteran status, or other groups as protected by law.